By [Staff Writer] | Published: [Date]

The connected health sector is entering a period of accelerated maturation, driven by converging forces: post-pandemic care delivery preferences, a tightening regulatory environment around data interoperability, and—most critically—a fundamental shift in how public and private payers reimburse for remote patient monitoring (RPM) and virtual care. While the industry has long touted the potential of connected devices to reduce hospital readmissions and manage chronic disease, 2025 is shaping up as the year when scalable economics finally match the technology’s clinical promise.

RPM Utilization Hits New Benchmarks

According to the latest quarterly data from the Healthcare Information and Management Systems Society (HIMSS) and analytics firm Definitive Healthcare, the number of active RPM programs across U.S. health systems grew by 34% year-over-year in Q1 2025. More notably, the average number of patient-monitoring days per enrolled individual increased by 22%, suggesting that adoption is moving beyond pilot projects into routine clinical workflows.

This growth is not uniform, however. While cardiology and endocrinology remain the dominant specialties—accounting for nearly 60% of all RPM device activations—the fastest-growing segment is post-surgical orthopedic monitoring. Wearable sensors that track joint range of motion, incision-site temperature, and step count are now being bundled into standard discharge protocols at several large academic medical centers, including the Cleveland Clinic and Mayo Clinic’s Florida campus.

“We’re seeing a shift from ‘monitoring for alarms’ to ‘monitoring for trajectories,’” said Dr. Elena Vasquez, chief digital health officer at a large Midwestern health system, speaking at the Connected Health Conference in Boston last week. “The devices are no longer just telling us when a patient is crashing. They are telling us when a patient is subtly improving or plateauing, which allows us to adjust medications and physical therapy remotely. That is a workflow change, not just a tech add-on.”

Regulatory and Reimbursement Alignment

The most significant structural development this quarter came from the Centers for Medicare & Medicaid Services (CMS). In its final 2025 Physician Fee Schedule, CMS not only maintained the expanded RPM CPT codes (99453, 99454, 99457, and 99458) but also introduced a new add-on code for “asynchronous remote care plan review” specifically for patients with two or more chronic conditions. This code, effective January 1, 2025, reimburses providers for time spent reviewing device data and adjusting care plans without requiring a synchronous telemedicine visit.

Industry analysts view this as a direct response to the criticism that previous RPM reimbursement models incentivized data collection but not clinical interpretation. “The old model was, ‘stick a blood pressure cuff on the patient and bill for the data transmission,’” noted Marcus Chen, senior analyst at the healthcare investment bank TripleTree. “The new code pays for the cognitive work. It’s a small reimbursement—roughly $18 to $24 per 20-minute increment—but it signals that CMS wants connected health to be a clinical service, not a device rental program.”

On the private payer side, the news is more mixed but trending positive. Two of the nation’s largest commercial insurers—UnitedHealth Group and Elevance Health—announced in late April that they would expand their virtual care and RPM coverage to include continuous glucose monitors (CGMs) for all Type 2 diabetes patients, not just those on intensive insulin therapy. This aligns with the American Diabetes Association’s 2025 Standards of Care, which now recommend CGM use for any adult with Type 2 diabetes who is not meeting glycemic targets.

Interoperability Finally Moves from Promise to Practice

A perennial pain point in connected health—the lack of seamless data exchange between device manufacturers, electronic health records (EHRs), and payer systems—is showing tangible signs of resolution. The adoption of the HL7 FHIR (Fast Healthcare Interoperability Resources) standard, coupled with the Office of the National Coordinator for Health IT’s (ONC) updated certification criteria, has led to a wave of new API integrations.

In February, Apple and Epic Systems announced a joint partnership to allow patients to share their Health app data (including heart rate, oxygen saturation, and sleep patterns) directly into Epic’s MyChart portal via FHIR-based APIs, without requiring a third-party intermediary app. While similar announcements have been made in the past, this integration is notable because it includes a two-way consent management system, allowing patients to revoke access at any time and to view exactly which data points are being shared.

“Interoperability is no longer a technical problem; it’s a trust problem,” said Dr. Priya Ramanathan, chief medical information officer at a large California-based hospital network. “Patients are willing to share data if they understand the value exchange. But they are also increasingly savvy about privacy. The platforms that succeed will be the ones that make consent granular, transparent, and reversible.”

Trend Watch: The Rise of Ambient and Continuous Sensing

Beyond traditional RPM, the connected health industry is seeing rapid growth in “ambient sensing” technologies—devices that monitor patients passively without requiring them to wear anything. These include radar-based fall detection systems, in-home motion sensors that track sleep and activity patterns, and acoustic sensors that can detect changes in respiratory rate or cough frequency.

The market for such technologies, often bundled under the umbrella of “aging in place” solutions, is projected to reach $12.5 billion by 2027, according to a recent report from Grand View Research. Several U.S. states, including Minnesota and Massachusetts, have begun pilot programs that reimburse for passive in-home monitoring as part of Medicaid waiver programs for older adults with multiple chronic conditions.

However, experts caution that ambient sensing introduces new ethical and logistical challenges. “Unlike a wearable that the patient chooses to put on, ambient sensors are always on,” noted Dr. Vasquez. “This raises questions about autonomy and surveillance, especially for patients with cognitive impairment. We need clear guidelines on who can access this data, and under what circumstances it can be used to trigger interventions—or to deny coverage.”

Expert Outlook: From Pilot Fatigue to Portfolio Management

A recurring theme among industry leaders at the recent American Telemedicine Association (ATA) annual meeting was the need to consolidate the fragmented landscape of connected health vendors. Many health systems have accumulated dozens of point solutions—one app for blood pressure, another for glucose, another for medication adherence—leading to clinician alert fatigue and poor patient engagement.

“The next big differentiator is not a new sensor or a new algorithm. It’s the orchestration layer,” said Chen. “Health systems are asking: can we have one platform that ingests data from 20 different devices, normalizes it, applies clinical rules, and routes it to the right care team member? That’s where the value creation is happening now.”

Dr. Ramanathan echoed this sentiment, adding that the ultimate measure of success will be clinical outcomes, not device activations. “We have to be honest with ourselves. Connected health is a tool, not a strategy. If we don’t see a reduction in HbA1c, blood pressure, or hospital admissions, then we are just generating noise. The industry is moving past the novelty phase. The question is no longer ‘Can we do this?’ but ‘Should we do this for every patient, and how do we prove it works?’”

Looking Ahead

As the second half of 2025 approaches, the connected health landscape is characterized by cautious optimism. Regulatory reimbursement is aligning, interoperability is improving, and clinical evidence is accumulating. Yet challenges remain: the digital divide persists, with rural and lower-income populations still less likely to have access to broadband or compatible devices. Additionally, the cybersecurity risk of an increasingly connected medical device ecosystem continues to be a top concern for hospital CISOs.

For now, the consensus among stakeholders is that connected health has crossed a critical threshold. It is no longer an experimental adjunct to traditional care but a core component of chronic disease management and post-acute care. The winners in this space will be those who can integrate data seamlessly, engage patients meaningfully, and demonstrate value in terms that payers and providers both understand: better outcomes at a sustainable cost.